PUBLISHER: The Business Research Company | PRODUCT CODE: 1942551
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942551
Cerebrospinal fluid management (CSF) devices and equipment play a crucial role in treating hydrocephalus, a condition characterized by the excessive accumulation of CSF within the brain.
The primary categories of cerebrospinal fluid (CSF) management devices and equipment include CSF shunts and CSF drainage systems. CSF shunts serve as the key devices for hydrocephalus treatment, featuring silastic tubes that redirect CSF from the ventricles to other body cavities, such as the peritoneum, the right cardiac atrium, or the pleural space. CSF drainage system types, including ventricular drainage systems and lumbar drainage systems, are utilized across different age groups, encompassing pediatric, adult, and geriatric patients. Hospitals and ambulatory surgical centers represent the various end-users of these devices.
Tariffs are influencing the cerebrospinal fluid management devices and equipment market by increasing costs of imported medical-grade polymers, valves, sensors, and precision tubing used in shunts and drainage systems. Hospitals in North America and Europe are most affected due to dependence on imported neurosurgical components, while Asia-Pacific faces manufacturing cost pressures. These tariffs are raising device prices and impacting procurement budgets. However, they are also supporting domestic production, localized component sourcing, and innovation in cost-effective CSF management technologies.
The cerebrospinal fluid management (csf) devices and equipment market research report is one of a series of new reports from The Business Research Company that provides cerebrospinal fluid management (csf) devices and equipment market statistics, including cerebrospinal fluid management (csf) devices and equipment industry global market size, regional shares, competitors with a cerebrospinal fluid management (csf) devices and equipment market share, detailed cerebrospinal fluid management (csf) devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cerebrospinal fluid management (csf) devices and equipment industry. This cerebrospinal fluid management (csf) devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cerebrospinal fluid management (csf) devices and equipment market size has grown strongly in recent years. It will grow from $1.21 billion in 2025 to $1.28 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increasing diagnosis of hydrocephalus cases, expansion of neurosurgical treatment centers, rising adoption of shunt-based therapies, availability of advanced drainage systems, growing pediatric neurology care.
The cerebrospinal fluid management (csf) devices and equipment market size is expected to see strong growth in the next few years. It will grow to $1.64 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing demand for smart and adjustable csf shunts, rising focus on infection-resistant materials, expansion of geriatric neurosurgical care, growing investments in neurological disorder management, technological advancements in intracranial pressure monitoring. Major trends in the forecast period include increasing adoption of programmable shunt systems, rising use of minimally invasive csf drainage devices, growing integration of pressure monitoring technologies, expansion of pediatric hydrocephalus treatments, enhanced focus on long-term patient management.
The increasing prevalence of neurological disorders is expected to drive the growth of the cerebrospinal fluid (CSF) devices market in the coming years. Neurological disorders are defined as conditions that affect the brain, spinal cord, and the nerves throughout the body. Cerebrospinal fluid (CSF) devices are used to diagnose, monitor, and treat these disorders, thereby improving patients' quality of life. For example, according to the 2023 Alzheimer's Disease Facts and Figures by the Alzheimer's Association, Alzheimer's and other dementias will cost the United States $345 billion in 2023, with projections reaching nearly $1 trillion by 2050. Consequently, the rising prevalence of neurological disorders is fueling the expansion of the cerebrospinal fluid (CSF) devices market.
The increase in brain surgeries is also contributing to the growth of the cerebrospinal fluid (CSF) devices market. CSF devices are critical in managing traumatic brain injury (TBI); shunts are commonly used to drain excess cerebrospinal fluid accumulated near the brain. In the United States, TBI is a leading cause of death, with approximately 1.5 to 2 million adults and children affected each year. Among the 1.1 million individuals who sustain head injuries, 235,000 are hospitalized with moderate to severe cases, while around 50,000 fatalities occur. The majority, however, experience mild injuries that do not require hospitalization. The rising incidence of brain injuries is therefore expected to sustain growth in the CSF devices market.
Companies in the CSF devices market are developing innovative products to meet unmet medical needs. One notable example is the ReFlow Mini Flusher device, designed to treat hydrocephalus, a condition characterized by excessive accumulation of cerebrospinal fluid in the brain. Launched in July 2023, this small, implantable system combines a flushing device with a ventricular catheter. Its compact design, ease of use, and reduced profile make it a promising advancement in hydrocephalus treatment.
Major companies operating in the cerebrospinal fluid management (csf) devices and equipment market are Medtronic plc, Johnson & Johnson Services Inc, B. Braun Melsungen AG, Integra LifeSciences Holdings Corporation, Sophysa S.A, Spiegelberg GmbH & Co. KG, Natus Medical Incorporated, Moller Medical GmbH, Dispomedica GmbH, Raumedic AG, Christoph Miethke GmbH & Co. KG, Flowonix Medical Inc, Phoenix Biomedical Corporation, Orsan Medical Technologies, Beckersmith Medical Inc, SOMATEX Medical Technologies, Neurosign, Medsit Medical, Delta Surgical Limited, G. Surgiwear Ltd, Tokibo Co. Ltd, Nikkiso Co. Ltd, Medtronic Neuro
North America was the largest region in the global cerebrospinal fluid (CSF) management devices and equipment market in 2025. Asia-Pacific was the second-largest region in the cerebrospinal fluid (CSF) management devices and equipment market. The regions covered in the cerebrospinal fluid management (csf) devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cerebrospinal fluid management (csf) devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The cerebrospinal fluid management (CSF) devices and equipment market consists of sales of ventricular drainage system, lumbar drainage system that are used for the treatment of hydrocephalus. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cerebrospinal Fluid Management (CSF) Devices And Equipment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cerebrospinal fluid management (csf) devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cerebrospinal fluid management (csf) devices and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cerebrospinal fluid management (csf) devices and equipment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.